跳到正文
原文
Endpoints News 生物医药· Kyle LaHucik·· 15 天前AI 评分20

Caldera 和 Evommune 签署中国特许权协议

Caldera, Evommune sign China licensing deals for autoimmune drugs

AI 导读

Caldera 和 Evommune 近日与中国签署特许权协议,进一步推动自身免疫疾病药物在中国的市场布局。

正文

The bio­phar­ma in­dus­try was al­ready on pace for one Chi­na deal per week for the en­tire year. Now, an­oth­er two biotechs have …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news